HawkEye 360 Brings Real Defense-Tech Scale to the IPO Calendar
HawkEye 360's roadshow turns a space IPO into a defense-data test
By Erik Aronesty · Published April 30, 2026 · HawkEye 360, Inc. · HAWK
NEW YORK, April 30, 2026 — HawkEye 360 is not showing up as another thin, story-stock space deal. The company launched its roadshow on April 27 for 16 million shares at $24 to $26, a setup that would raise up to $416 million before greenshoe, with Goldman Sachs and Morgan Stanley atop a syndicate that runs through RBC, Jefferies, BofA, Baird, Raymond James, William Blair, and Drexel Hamilton. For IPO readers, that alone puts HAWK on a different shelf than most orbital hopefuls.
The deeper reason to watch it is that HawkEye is selling scale and visibility, not just mission language. In its latest S-1/A, the company said 2025 revenue rose 74% to $117.7 million, while backlog reached $302.7 million at year-end versus $44.1 million a year earlier. Existing customers generated 90% of 2025 revenue. That is backed by operating color outside the prospectus: HawkEye in March announced a program valued at up to $75 million with a European Ministry of Defense, and earlier this year it launched Cluster 13 as it keeps expanding the constellation behind the product pitch.
Still, the amended filing also shows why this book should trade more like a defense-data underwrite than a pure software scarcity story. HawkEye disclosed preliminary first-quarter 2026 revenue of $48.2 million to $50.2 million, up from $23.0 million a year earlier, but said net loss likely widened to $9.5 million to $11.9 million from $1.6 million. The same filing says IPO proceeds are slated first for balance-sheet work: $49.8 million to repay senior and mezzanine borrowings and $7.5 million for a deferred payment tied to the December 2025 ISA acquisition, with the remainder for working capital and general corporate purposes. HawkEye also raised about $23 million of additional Series E capital in March, a sign that private investors were still leaning in just weeks before the roadshow.
The open question is how much public investors will pay for a business with real demand signals but concentrated exposure. HawkEye says the top ten customers represented about 96% of backlog at December 31, 2025, and it plans to elect public-benefit-corporation status at the IPO. That mix may cap the easy-growth narrative, but it also makes HawkEye one of the more substantive issuers on the active calendar: a company with revenue, backlog, acquisition integration, and a serious bank group, rather than another concept stock selling future orbit. Renaissance Capital expects the deal to price the week of May 4.